Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Aurora Cannabis

SNDL Inc.

Pot Stocks In Mid July 2022 The post Top Canadian Cannabis Stocks To Watch Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Cannabis Stocks To Watch Right Now

Anheuser-Busch InBev

Constellation Brands

Molson Coors Brewing

We still think the industry will grow significantly in the coming years. But we don't think cannabis stocks will score investors big returns.

Ditch the Losing Game in Cannabis Stocks for Much Greener Pastures

Multiple headwinds weighed on the cannabis giant's shares last month.

Why Canopy Growth Stock Cratered in June

HEXO Corp

Tilray Brands

Canadian Marijuana Stocks To Keep On Your Radar The post 3 Canadian Marijuana Stocks To Buy In July? appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

3 Canadian Marijuana Stocks To Buy In July?

Canaccord Genuity (TSX:CF, LSE:CF) slashed its price target on Canopy Growth Corp following news of the cannabis company's plan to convert nearly C$253 million of unsecured convertible notes into equity – a move analysts decried as dilutive. The investment bank downgraded its target to C$3.50 from C$4.50 and reiterated its ‘Sell' rating on the stock.

Canopy Growth price target slashed to C$3.50 by Canaccord Genuity after converting unsecured notes into equity

Canopy Growth has burned investors, and a rebound isn't a sure thing.

This Former Market Darling Is More Weed Than Flower

Not for the first time in the company's history, an analyst cuts his price target on its stock.

Why Canopy Growth Wilted as the Market Grew Today

Agrify

Akanda Corp

Cronos Group

Greenlane Holdings

Innovative Industrial Properties

Akerna Corp

WM Technology

Turning Point Brands

Urban-gro

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks this week, and look ahead to how the cannabis industry will continue to develop in 2022.

Are These Cannabis Stocks Heating Up or Just Blowing Smoke?

SMITHS FALLS, ON , June 30, 2022 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) announced today that, further to its press release dated June 29, 2022, it has entered into an additional privately negotiated exchange agreement (the "Exchange Agreement") with a holder (the "Noteholder") of the Company's outstanding 4.25% unsecured senior notes due 2023 (the "Notes"), to acquire approximately C$7.25 million (approximately USD$5.6 million) aggregate principal amount of the Notes from the Noteholders in exchange for common shares of the Company (the "Canopy Shares") and approximately C$140,000 (approximately USD$110,000) in cash for accrued and unpaid interest (the "Cash Payment"). Transaction Details In accordance with the terms of the Exchange Agreement, Canopy Growth has agreed to acquire the Notes from the Noteholder for an aggregate purchase price (excluding accrued and unpaid interest which will be paid in cash as part of the Cash Payment) of C$7.17 million (approximately USD$5.5 million) (the "Purchase Price"), which will be payable in such number of Canopy Shares (the "Share Consideration") as is equal to the Purchase Price divided by the volume-weighted average trading price (the "VWAP") of the Canopy Shares on the Nasdaq Global Select Market (the "Nasdaq") for the 10 consecutive trading days beginning on, and including, June 30, 2022 (the "Averaging Price" and such period of time being the "Averaging Period"), subject to a floor price of US$2.50 (the "Floor Price") and a maximum price equal to US$3.50, which is the closing price of the Canopy Shares on the Nasdaq on June 29, 2022 (the "Market Price").

Canopy Growth Announces Additional Exchanges with Holders of Notes

Canopy Growth (CGC) stock is falling Thursday on news that Constellation Brands (STZ) is planning to eliminate its Class B shares. The post Why Is Canopy Growth (CGC) Stock Plunging 20% Today?

Why Is Canopy Growth (CGC) Stock Plunging 20% Today?

The Canadian cannabis operator announced a dilution-causing convertible notes exchange.

Why Canopy Growth Stock Is Tanking Today

Canopy Growth Corp. CGC, -3.05% WEED, -3.23% fell 17% in premarket trades on Thursday after the company said it reached an agreement with Constellation Brands Inc. STZ, -0.77% to convert about $198 million of convertible debt into stock. Constellation agreed to acquire between 21.93 million or 5.4% of Canopy stock and 30.7 million shares or 7.6% of Canopy stock that will convert from debt.

Canopy Growth shares fall after it agrees to convert debt into stock in deal with Constellation Brands

Leading global cannabis company continues to expand beverage portfolio with exciting new products SMITHS FALLS, ON , June 30, 2022 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC), a world-leading diversified cannabis, hemp, and cannabis device company, today announced the continued expansion of its cannabis beverage portfolio and a brand campaign that drives awareness of its wide range of cannabis beverages just in time for the summer season. Boasting the category's fastest growing brands,1 Canopy Growth continues to show its leadership in beverages and ongoing commitment to meeting customer demand.

Canopy Growth Celebrates Summer with New 'Just Hits Different' Beverage Campaign

SMITHS FALLS, ON , June 29, 2022 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC) announced today that it has entered into privately negotiated exchange agreements (collectively, the "Exchange Agreements") with a limited number of holders (the "Noteholders"), including Constellation Brands, Inc. ("CBI") through its wholly-owned subsidiary Greenstar Canada Investment Limited Partnership ("GCILP"), of the Company's outstanding 4.25% unsecured convertible senior notes due 2023 (the "Notes"), to acquire approximately C$255.4 million (approximately USD$198 million) aggregate principal amount of the Notes from the Noteholders (the "Transaction") in exchange for common shares of the Company (the "Canopy Shares") and approximately C$3 million (USD$2.35 million) in cash for accrued and unpaid interest (the "Cash Payment"). GCILP, a subsidiary of CBI (together "Constellation"), is participating in the Transaction and will acquire a minimum of 21,929,914 Canopy Shares and up to 30,701,880 Canopy Shares pursuant to its Exchange Agreement.

Canopy Growth Announces Exchanges with Holders of Approximately US$198 Million of Convertible Notes

There could be light at the end of the tunnel, but time will tell.

Can These Beaten-Down Growth Stocks Be Revived?

A top credit rating agency is taking a dimmer view of the cannabis company.

Why Canopy Growth Stock Couldn't Catch a Buzz Today

Fitch Ratings on Monday downgraded its debt rating on Canopy Growth Corp. CGC, -1.45% WEED, -2.04% and said uncertainty remains whether the company can sustain its capital structure. "It is highly doubtful that Canopy can improve [its] earnings before interest, taxes, depreciation and amortization (Ebitda) to reach operating cash flow breakeven in fiscal 2025 as Fitch previously expected," the ratings firm said.

Canopy Growth credit rating hit on market share losses in Canadian cannabis market

Will These Marijuana Stocks Uplist If The CLIMB Act Becomes Law The post The CLIMB Act May Help Marijuana Stocks Trade Better appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

The CLIMB Act May Help Marijuana Stocks Trade Better

AFC Gamma

Amplify Seymour Cannabis ETF

Curaleaf Holdings, Inc.

GrowGeneration Corp

Hydrofarm Holdings Group

Amplify Alternative Harvest ETF

AdvisorShares Pure US Cannabis ETF

NewLake Capital Partners, Inc.

Global X Cannabis ETF

Power REIT

Chicago Atlantic Real Estate Finance

Scotts Miracle-Gro

Trulieve Cannabis Corp.

Cambria Cannabis ETF

Village Farms International

AdvisorShares Pure Cannabis ETF 

Cannabis REITs - a perennial performance leader over the past half-decade - have been slammed in 2022 amid concerns over tenant financial health given the sharp re-pricing of risk and tighter financial conditions. Owning the "Pharmland" - the physical real estate - had been one of the few cannabis plays that was working amid a decade-long stretch of dismal investment performance from broader cannabis ETFs.

Cannabis REITs: Weeding Out The Weak

Canadian Pot Stocks For Short Term Trading In June The post Are Canadian Marijuana Stocks A Buy Right Now? 3 With Fresh Lows This Week appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are Canadian Marijuana Stocks A Buy Right Now? 3 With Fresh Lows This Week

Tilray just greatly improved the terms for its previously announced investment in Hexo.

Here's Why Tilray and Canopy Growth Jumped Tuesday but Hexo Crashed

Clever Leaves Holdings Inc

High Tide

InMed Pharmaceuticals

Neptune Wellness Solutions Inc.

This Week's Cannabis Stock News: 7 Companies Make Headlines

OrganiGram Holdings Inc.

Is It Time For Active Traders To Buy Canadian Pot Stocks? The post Top Canadian Marijuana Stocks On The Nasdaq In June appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Top Canadian Marijuana Stocks On The Nasdaq In June

Until it fixes both of these issues, it's unlikely the business will post a profit.

2 Extremely Concerning Metrics From This Growth Stock's Q4 Results

Green Thumb Industries Inc.

Curaleaf will likely experience even more growth in the years ahead.

This Cannabis Company Is Expecting a "Very Substantial Growth Year" in 2022

News for Canopy Growth Stock (CGC)